Hip implants with a delta ceramic or oxidized zirconium head and highly crosslinked polyethylene liner or cup had the lowest risk of revision during the 15 years after surgery, a new study has found.

A single injection of denosumab (Prolia, Amgen), frequently used to treat osteoporosis, may reduce the need for revision surgery in patients with symptomatic osteolysis following total hip ...

Seoul National University Hospital has performed South Korea's first robot-assisted revision surgery for artificial hip ...

More than half of repeat hip replacement operations could be prevented with a drug already successfully used to treat osteoporosis, new research from the University of Sheffield and Sheffield Teaching ...

Along with age and injuries, obesity is a leading risk factor for osteoarthritis (OA), a painful and disabling joint disease. While excessive weight can aggravate the toll on almost any joint, obesity ...

Please provide your email address to receive an email when new articles are posted on . A popular bearing surface from the 1990s to the mid-2000s, published literature estimated more than 1 million ...

Hip implants with a delta ceramic or oxidized zirconium head and highly crosslinked polyethylene liner or cup had the lowest risk of revision during the 15 years after surgery, a new study led by the ...

Researchers have found the osteoporosis drug, denosumab, could protect patients from osteolysis, reduce the need for re-operations, and reduce the health burden of this disease. More than half of ...